IRF4-activated TEX41 promotes the malignant behaviors of melanoma cells by targeting miR-103a-3p/C1QB axis
Y Zheng, W Zhou, M Li, R Xu, S Zhang, Y Liu, Y Cen - Bmc Cancer, 2021 - Springer
Background Malignant melanoma is an aggressive skin cancer and a tumor of melanocytic
origin. Recent studies have suggested that long non-coding RNAs (lncRNAs) play crucial …
origin. Recent studies have suggested that long non-coding RNAs (lncRNAs) play crucial …
Detection of 22 common leukemic fusion genes using a single-step multiplex qRT-PCR-based assay
X Lyu, X Wang, L Zhang, Z Chen, Y Zhao, J Hu… - Diagnostic …, 2017 - Springer
Background Fusion genes generated from chromosomal translocation play an important role
in hematological malignancies. Detection of fusion genes currently employ use of either …
in hematological malignancies. Detection of fusion genes currently employ use of either …
[HTML][HTML] Co-existence of RUNX1-RUNX1T1 and BCR-ABL1 in acute myeloid leukemia: a case report
S Park, JR Shim, JH Lee, JY Han - Blood research, 2023 - synapse.koreamed.org
TO THE EDITOR: Acute myeloid leukemia (AML) with t (8; 21)(q22; q22. 1), which results in
RUNX1-RUNX1T1 gene fusion, is usually associated with a high rate of complete remission …
RUNX1-RUNX1T1 gene fusion, is usually associated with a high rate of complete remission …
MET canonical transcript expression is a predictive biomarker for chemo-sensitivity to MET-inhibitors in hepatocellular carcinoma cell lines
WM Rashed, MA Kandeil, MO Mahmoud… - Journal of cancer …, 2021 - Springer
Purpose Long interspersed nuclear element 1 (LINE-1 or L1) is a dominant non-long
terminal repeat (non-LTR) retrotransposon in the human genome that has been implicated …
terminal repeat (non-LTR) retrotransposon in the human genome that has been implicated …
The use of transcriptomics in clinical applications
DM Borràs, B Janssen - Integration of Omics Approaches and …, 2018 - Wiley Online Library
Currently available sequencing technologies allow for the use of transcriptomics for clinical
applications. Screening for multiple disease determinants, obtaining information on disease …
applications. Screening for multiple disease determinants, obtaining information on disease …
A case of acute promyelocytic leukemia with co-existence of BCR-ABL1 and PML-RARA rearrangements detected by PCR
GD An, HH Lim, KS Woo, KH Kim… - Laboratory …, 2017 - synapse.koreamed.org
Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML)
characterized by PML-RARA fusion and specific morphology. The BCR-ABL1 …
characterized by PML-RARA fusion and specific morphology. The BCR-ABL1 …
Reacción en cadena de polimerasa transcriptasa inversa para diagnóstico de leucemia mieloide crónica Cuenca 2013-2017
MJ Arcentales Cayamcela - 2018 - dspace-test.ucuenca.edu.ec
Objetivo General: Determinar la prevalencia del gen de fusión BCR/ABL p210 mediante la
técnica de Reacción en Cadena de la Polimerasa Transcriptasa Inversa (RT-PCR) en …
técnica de Reacción en Cadena de la Polimerasa Transcriptasa Inversa (RT-PCR) en …
PCR 로확인한PML-RARA 와BCR-ABL1 재배열이동시에동반된급성전골수구백혈병1 예
안규대， 임현호， 우광숙， 김경희， 김정만… - Laboratory Medicine …, 2017 - dbpia.co.kr
급성전골수구백혈병은 PML-RARA 유전자 이상과 특징적인 형태를 가진 급성 골수성백혈병의
한 종류이다. BCR-ABL1 유전자 이상은 주로 만성골수성백혈병 환자에게서 발견되는 유전자 …
한 종류이다. BCR-ABL1 유전자 이상은 주로 만성골수성백혈병 환자에게서 발견되는 유전자 …